Food & Drug Administration (FDA) announced it will convene the Pharmacy Compounding Advisory Committee (PCAC) on July 23 and 24, 2026, to discuss permitting compounding pharmacies to prepare certain peptides used for ulcerative colitis (UC), wound healing, obesity, insomnia, opioid withdrawal, inflammatory conditions, and osteoporosis, among other conditions
Choosing the Right Regenerative Medicine Clinic When youre exploring peptide therapy, the clinic you choose makes all the difference
Clinical Justification : Detailed reasons aligned with the patients medical condition necessitating the prescribed medication
What we do We start every program with an 80+ biomarker panel, an InBody 770 scan, a 60-minute provider consultation, and follow-up lab monitoring